2022
DOI: 10.1016/j.jvsv.2021.12.088
|View full text |Cite
|
Sign up to set email alerts
|

Systematic review and meta-analysis of management of incompetent perforators in patients with chronic venous insufficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 76 publications
0
3
0
Order By: Relevance
“…Another endoscopic surgery for vascular disease is the subfascial endoscopic perforator surgery, 4 which has been mainly used to manage incompetent perforators in patients with chronic venous insufficiency 24 . Some authors used subfascial endoscopic perforator surgery to treat the marginal vein in KTS 4 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Another endoscopic surgery for vascular disease is the subfascial endoscopic perforator surgery, 4 which has been mainly used to manage incompetent perforators in patients with chronic venous insufficiency 24 . Some authors used subfascial endoscopic perforator surgery to treat the marginal vein in KTS 4 .…”
Section: Discussionmentioning
confidence: 99%
“…Another endoscopic surgery for vascular disease is the subfascial endoscopic perforator surgery, 4 which has been mainly used to manage incompetent perforators in patients with chronic venous insufficiency. 24 Some authors used subfascial endoscopic perforator surgery to treat the marginal vein in KTS. 4 However, endovenous radiofrequency ablation, 18 , 20 sclerotherapy, 25 and ethanol embolization 15 have become the mainstay for managing the marginal vein in recent years with the development of endovenous interventional techniques.…”
Section: Discussionmentioning
confidence: 99%
“…Previous systematic reviews and meta-analyses have provided valuable insights into the outcomes of sclerotherapy in CVI. However, these studies have focused on specific patient populations or compared sclerotherapy with other interventions, limiting the generalizability of their findings [ 10 ].…”
Section: Introductionmentioning
confidence: 99%